Escherichia coli compositions and methods thereof

In one aspect, the invention relates to an immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines may be prepared by combining two or more monovalent immunogenic compositions for different E. coli s...

Full description

Saved in:
Bibliographic Details
Main Authors Srinivas KODALI, Annaliesa Sybil ANDERSON, Rosalind PAN, Laurent Oliver CHORRO, Karen Kiyoko TAKANE, Ling CHU, Avvari Krishna PRASAD, Nishith MERCHANT, Mark Edward RUPPEN, Jianxin GU, Jason Arnold LOTVIN, Justin Keith MORAN, Suddham SINGH, Scott Ellis LOMBERK, Wei CHEN, Robert G. K. DONALD, Jin-Hwan KIM
Format Patent
LanguageEnglish
Hebrew
Published 01.03.2024
Subjects
CHEMISTRY
COMPOSITIONS BASED THEREON
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
ORGANIC MACROMOLECULAR COMPOUNDS
PEPTIDES
POLYSACCHARIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
THEIR PREPARATION OR CHEMICAL WORKING-UP
Online AccessGet full text

Cover

More Information
Summary:In one aspect, the invention relates to an immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines may be prepared by combining two or more monovalent immunogenic compositions for different E. coli serotypes. In one embodiment, the modified O-polysaccharide molecules are produced by a recombinant bacterium that includes a wzz gene.
Bibliography:Application Number: IL20210281094